Aztreonam contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Contraindications== | ==Contraindications== | ||
This preparation is contraindicated in patients with known hypersensitivity to aztreonam or any other component in the formulation. | This preparation is contraindicated in patients with known hypersensitivity to aztreonam or any other component in the formulation.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AZACTAM (AZTREONAM) INJECTION, POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a105eaf-ee77-4016-beeb-d425a5565db2#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | ||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AZACTAM (AZTREONAM) INJECTION, POWDER, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a105eaf-ee77-4016-beeb-d425a5565db2#nlm34089-3 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 00:07, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
This preparation is contraindicated in patients with known hypersensitivity to aztreonam or any other component in the formulation.[1]
References
Adapted from the FDA Package Insert.